Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Arcutis Biotherapeutics, Inc. (ARQT) had Return on Equity of -88.89% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$196.54M |
|
$-140.04M |
|
$19.13M |
|
$177.41M |
|
$324.94M |
|
$-128.40M |
|
$-10.99M |
|
$-139.39M |
|
$-139.39M |
|
$-140.04M |
|
$-140.04M |
|
$-140.04M |
|
$-140.04M |
|
$-128.40M |
|
$-132.70M |
|
120.96M |
|
120.96M |
|
$-1.16 |
|
$-1.16 |
|
| Balance Sheet Financials | |
$335.82M |
|
$1.04M |
|
$13.07M |
|
$348.89M |
|
$81.01M |
|
$107.20M |
|
$110.33M |
|
$191.35M |
|
$157.54M |
|
$148.06M |
|
$157.54M |
|
117.85M |
|
| Cash Flow Statement Financials | |
$-112.16M |
|
$28.82M |
|
$66.20M |
|
$89.32M |
|
$71.95M |
|
$-17.37M |
|
$41.73M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.15 |
|
-- |
|
-- |
|
0.40 |
|
0.68 |
|
90.27% |
|
-65.33% |
|
-65.33% |
|
-67.52% |
|
-70.92% |
|
-71.25% |
|
$-112.30M |
|
-- |
|
-- |
|
-- |
|
0.56 |
|
1.32 |
|
2.69 |
|
135.69 |
|
|
Return on Equity |
-88.89% |
-94.58% |
|
-40.14% |
|
-52.90% |
|
$1.34 |
|
$-0.93 |
|
$-0.93 |
|